Delcath Systems, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
DCTH Over the counter 3841 http://delcath.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Delcath Systems, Inc.

Delcath Systems Announces Rights Offering and Backstop Commitment Ownership Date of August 1, 2018 - Jul 16th, 2018 6:00 am
Delcath Announces 100th Commercial CHEMOSAT Treatment Completed at Leiden University Medical Center, The Netherlands - Jul 9th, 2018 6:00 am
Delcath Systems to Present at the 8th Annual LD Micro Invitational - May 29th, 2018 6:30 am
Delcath Sponsors Looking For A Cure Ocular Melanoma Charity Event - May 22nd, 2018 6:15 am
Delcath’s CHEMOSAT Included in German Treatment Guidelines for Melanoma Liver Metastases - May 16th, 2018 6:00 am
Delcath’s PHP Therapy Featured in Video Learning Session at the European Conference of Interventional Oncology  - May 14th, 2018 6:00 am
Delcath Announces First Quarter 2018 Financial Results - May 10th, 2018 6:00 am
Delcath Announces Initiation of Registrational Trial of Melphalan/HDS in Intrahepatic Cholangiocarcinoma - May 7th, 2018 6:00 am
Delcath to Present at the RHK Capital 2018 Disruptive Growth and Healthcare Conference - May 4th, 2018 7:29 am
Delcath Announces Another DSMB Recommendation for Phase 3 Focus Trial - May 3rd, 2018 6:30 am
Delcath Announces Ratio for Reverse Split Authorization - May 1st, 2018 6:00 am
OTCQX And OTCQB Companies to Present At 2018 ROTH Conference - Mar 8th, 2018 8:00 am
Today's Research Reports on Stocks to Watch: Delcath and MGT Capital Investments - Feb 20th, 2018 6:30 am